Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10017592HBVENSG00000116016.14protein_codingEPAS1NoNo2034Q99814
TVIS10017800HBVENSG00000116016.14protein_codingEPAS1NoNo2034Q99814
TVIS10017801HBVENSG00000116016.14protein_codingEPAS1NoNo2034Q99814
TVIS10017802HBVENSG00000116016.14protein_codingEPAS1NoNo2034Q99814
TVIS10017803HBVENSG00000116016.14protein_codingEPAS1NoNo2034Q99814
TVIS30083715HIVENSG00000116016.14protein_codingEPAS1NoNo2034Q99814
TVIS44000423HTLV-1ENSG00000116016.14protein_codingEPAS1NoNo2034Q99814
TCGA Plot Options
Drug Information
GeneEPAS1
DrugBank IDDB15463
Drug NameBelzutifan
Target IDBE0009679
UniProt IDQ99814
Regulation Typeinhibitor
PubMed IDs
CitationsTai W. Wong, Rajeev Shrimali, Cristina Contreras, Tzuling Cheng, Robert M. Czerwinski, Daryl D. Dixon, Xinlin Du, Craig Fett, Jessica Goree, Jonas A. Grina, Guangzhou Han, Heli Huang, Jim Rizzi, Stephen T. Schlachter, Bin Wang, Keshi Wang, Paul M. Wehn, Shanhai Xie, Rui Xu, Hanbiao Yang, John A. Josey and Eli M. Wallace: Abstract B140: PT2977, a novel HIF-2a antagonist, has potent antitumor activity and remodels the immunosuppressive tumor microenvironment in clear cell renal cell cancer AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics.
GroupsApproved; Investigational
Direct Classification
SMILESCS(=O)(=O)C1=CC=C(OC2=CC(=CC(F)=C2)C#N)C2=C1[C@H](O)[C@H](F)[C@@H]2F
Pathways
PharmGKBPA166268761
ChEMBLCHEMBL4585668